Rhovac wants to raise more than a million dollars on the stock exchange

The listed Danish company Rhovac issues new shares for up to USD 3 million, which will finance new research activities as well as speed up the company's search for a potential buyer for its cancer vaccine.

Photo: /ritzau Scanpix/Jens Panduro

Log in to read our articles

Welcome to MedWatch. A part of our content is exclusive and reserved for our users.

Try us for 14 days

Try a trial subscription for access to our quality journalism

Related articles